EWTX · Forms 3, 4, 5
Insider trades at Edgewise Therapeutics, Inc.
5 insiders sold $1.9M of Edgewise Therapeutics, Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Edgewise Therapeutics, Inc. (EWTX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jonathan C Fox | Director | Award | 308 | Form 4 | |||
| Michael Nofi | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| Joanne M. Donovan | CMO | Sell (10b5-1 plan) | 2,919 | $43.41 | $127K | Form 4 | |
| Joanne M. Donovan | CMO | Option exercise | 5,781 | Form 4 | |||
| Joanne M. Donovan | CMO | Option exercise | 7,031 | Form 4 | |||
| Joanne M. Donovan | CMO | Sell | 2,839 | $43.78 | $124K | Form 4 | |
| Joanne M. Donovan | CMO | Sell | 2,779 | $43.71 | $121K | Form 4 | |
| Joanne M. Donovan | CMO | Sell | 104 | $44.43 | $5K | Form 4 | |
| Joanne M. Donovan | CMO | Sell | 800 | $44.52 | $36K | Form 4 | |
| Alan J Russell | Chief Scientific Officer | Option exercise | 5,781 | Form 4 | |||
| Alan J Russell | Chief Scientific Officer | Option exercise | 7,031 | Form 4 | |||
| Alan J Russell | Chief Scientific Officer | Sell | 3,238 | $43.68 | $141K | Form 4 | |
| Alan J Russell | Chief Scientific Officer | Sell | 2,273 | $43.68 | $99K | Form 4 | |
| Alan J Russell | Chief Scientific Officer | Sell | 390 | $44.46 | $17K | Form 4 | |
| John R Moore | General Counsel | Option exercise | 5,781 | Form 4 | |||
| John R Moore | General Counsel | Option exercise | 6,718 | Form 4 | |||
| John R Moore | General Counsel | Sell | 2,439 | $43.81 | $107K | Form 4 | |
| John R Moore | General Counsel | Sell | 59 | $44.41 | $3K | Form 4 | |
| John R Moore | General Counsel | Sell | 99 | $44.50 | $4K | Form 4 | |
| John R Moore | General Counsel | Sell | 2,419 | $43.80 | $106K | Form 4 | |
| Behrad Derakhshan | Chief Business Officer | Option exercise | 5,781 | Form 4 | |||
| Behrad Derakhshan | Chief Business Officer | Option exercise | 7,500 | Form 4 | |||
| Behrad Derakhshan | Chief Business Officer | Sell | 2,171 | $43.79 | $95K | Form 4 | |
| Behrad Derakhshan | Chief Business Officer | Sell | 304 | $44.50 | $14K | Form 4 | |
| Behrad Derakhshan | Chief Business Officer | Sell | 150 | $44.44 | $7K | Form 4 | |
| Behrad Derakhshan | Chief Business Officer | Sell | 2,475 | $43.70 | $108K | Form 4 | |
| Kevin Koch | President and CEO | Option exercise | 17,969 | Form 4 | |||
| Kevin Koch | President and CEO | Option exercise | 21,875 | Form 4 | |||
| Kevin Koch | President and CEO | Sell | 8,782 | $43.64 | $383K | Form 4 | |
| Kevin Koch | President and CEO | Sell | 8,276 | $43.66 | $361K | Form 4 | |
| Kevin Koch | President and CEO | Sell | 913 | $44.33 | $40K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.